Are residents of aged care facilities willing to have their medications deprescribed?

Research in Social and Administrative Pharmacy

Volumn 12, Issue 5, 2016, Pages 784-788

  Kalogianis, Mona J ^a   Wimmer, Barbara C ^a   Turner, Justin P ^a   Tan, Edwin C K ^a   Emery, Tina ^b   Robson, Leonie ^b   Reeve, Emily ^c,d   Hilmer, Sarah N ^c,d   Bell, J Simon ^a,c,e  

^a MONASH UNIVERSITY   (Australia)

^b Resthaven Incorporated   (Australia)

^c HORNSBY KU RING GAI HOSPITAL   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

^e UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

Author keywords

Aged; Attitudes toward deprescribing; Deprescribing; Long term care; Polypharmacy

Indexed keywords

AGED; ATTITUDE TO HEALTH; CROSS-SECTIONAL STUDY; DEPRESCRIPTION; DOCTOR PATIENT RELATION; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; FEMALE; HOME FOR THE AGED; HUMAN; MALE; NURSING HOME; POLYPHARMACY; PSYCHOLOGY; QUESTIONNAIRE; SOUTH AUSTRALIA; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ATTITUDE TO HEALTH; CROSS-SECTIONAL STUDIES; DEPRESCRIPTIONS; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; FEMALE; HOMES FOR THE AGED; HUMANS; MALE; NURSING HOMES; PHYSICIAN-PATIENT RELATIONS; POLYPHARMACY; SOUTH AUSTRALIA; SURVEYS AND QUESTIONNAIRES;

EID: 84956674002     PISSN: 15517411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sapharm.2015.12.004     Document Type: Article

References (11)

1. 1 Jokanovic, N., Tan, E.C., Dooley, M.J., et al. Prevalence and factors associated with polypharmacy in long-term care facilities: a systematic review. J Am Med Dir Assoc 16 (2015), 535.e1–535.e12.
2. 2 Maher, R.L., Hanlon, J., Hajjar, E.R., Clinical consequences of polypharmacy in elderly. Expert Opin Drug Saf 13 (2014), 57–65.
3. 3 Hugo, G., Contextualising the ‘Crisis in aged care’ in Australia: a demographic perspective. Aust J Soc Issues 19 (2007), 169–182.
4. 4 Scott, I.A., Hilmer, S.N., Reeve, E., et al. Reducing inappropriate polypharmacy: the process of deprescribing. JAMA Intern Med 175 (2015), 827–834.
5. 5 Tjia, J., Briesacher, B.A., Peterson, D., et al. Use of medications of questionable benefit in advanced dementia. JAMA Intern Med 174 (2014), 1763–1771.
6. 6 Reeve, E., Shakib, S., Hendrix, I., et al. Review of deprescribing processes and development of an evidence-based, patient-centred deprescribing process. Br J Clin Pharmacol 78 (2014), 738–747.
7. 7 Reeve, E., Wiese, M., Hendrix, I., et al. People's attitudes, beliefs and experiences regarding polypharmacy and willingness to deprescribe. J Am Geriatr Soc 61 (2013), 1508–1514.
8. 8 Qi, K., Reeve, E., Hilmer, S.N., Pearson, S.-A., Matthews, S., Gnjidic, D., Older peoples’ attitudes regarding polypharmacy, statin use and willingness to have statins deprescribed in Australia. Int J Clin Pharmcol 37 (2015), 949–957.
9. 9 Tan, E.C., Visvanathan, R., Hilmer, S.N., et al. Analgesic use, pain and daytime sedation in people with and without dementia in aged care facilities: a cross-sectional, multisite, epidemiological study protocol. BMJ Open, 4, 2014, e005757.
10. 10 Logsdon, R.G., Gibbons, L.E., McCurry, S.M., et al. Assessing quality of life in older adults with cognitive impairment. Psychosom Med 64 (2002), 510–519.
11. 11 Reeve, E., Shakib, S., Hendrix, I., et al. Development and validation of the patients' attitudes towards deprescribing (PATD) questionnaire. Int J Clin Pharm 35 (2013), 51–56.